middle.news
Arovella Releases First Clinical Batch and Activates Trial Site
9:00am on Monday 7th of September, 2026 AEST
•
Biotechnology
Read Story
Arovella Releases First Clinical Batch and Activates Trial Site
9:00am on Monday 7th of September, 2026 AEST
Key Points
First clinical batch of ALA-101 released for dosing
The Alfred hospital activated as first clinical trial site
Patient screening and enrolment underway, dosing expected soon
Off-the-shelf allogeneic therapy aims for faster, cheaper treatment
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Arovella Therapeutics (ASX:ALA)
OPEN ARTICLE